Prediction of hepatic and intestinal glucuronidation using in vitro–in vivo extrapolation
Authors:
- 1 February 2015
- journal article
- review article
- Published by Elsevier in Drug Metabolism and Pharmacokinetics
- Vol. 30 (1) , 21-29
Abstract
No abstract availableKeywords
This publication has 60 references indexed in Scilit:
- A Practical and Direct Comparison of Intrinsic Metabolic Clearance of Several Non-CYP Enzyme Substrates in Freshly Isolated and Cryopreserved HepatocytesDrug Metabolism and Pharmacokinetics, 2012
- Predicting Clearance in Humans from In Vitro DataCurrent Topics in Medicinal Chemistry, 2011
- Quantitative Prediction of Intestinal Metabolism in Humans from a Simplified Intestinal Availability Model and Empirical Scaling FactorDrug Metabolism and Disposition, 2010
- Intestinal glucuronidation metabolism may have a greater impact on oral bioavailability than hepatic glucuronidation metabolism in humans: A study with raloxifene, substrate for UGT1A1, 1A8, 1A9, and 1A10International Journal of Pharmaceutics, 2009
- DRUG-DRUG INTERACTIONS FOR UDP-GLUCURONOSYLTRANSFERASE SUBSTRATES: A PHARMACOKINETIC EXPLANATION FOR TYPICALLY OBSERVED LOW EXPOSURE (AUCI/AUC) RATIOSDrug Metabolism and Disposition, 2004
- Can the pharmaceutical industry reduce attrition rates?Nature Reviews Drug Discovery, 2004
- Predicting Human Drug Glucuronidation Parameters: Application of In Vitro and In Silico Modeling ApproachesAnnual Review of Pharmacology and Toxicology, 2004
- Complexities of Glucuronidation Affecting In Vitro-In Vivo ExtrapolationCurrent Drug Metabolism, 2002
- Prediction of in vivo drug metabolism in the human liver from in vitro metabolism dataPharmacology & Therapeutics, 1997
- First-pass metabolism of cyclosporin by the gutThe Lancet, 1991